Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uhi Toh

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Surgery Today|November 13, 2020
Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant techniqueUhi Toh, Miki Takenaka, Nobutaka Iwakuma, et al.
Molecular and Clinical Oncology|May 27, 2022
Immune responses of patients without cancer recurrence after a cancer vaccine over a long termShigetaka Suekane, Shigeru Yutani, Uhi Toh, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusionUhi Toh, Teruhiko Fujii, Naoko Seki, et al.
Breast Cancer (Tokyo, Japan)|August 22, 2014
Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancerMai Mishima, Uhi Toh, Nobutaka Iwakuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cells（CTC）in Patients with Metastatic Breast Cancer]Mina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
Experimental and Therapeutic Medicine|July 12, 2021
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccinesShuko Saku, Uhi Toh, Yuko Takao, et al.
Current Medicinal Chemistry|March 14, 2008
Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1Teruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Future Oncology (London, England)|March 17, 2009
YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cellsTeruhiko Fujii, Naoko Seki, Roka Namoto-Matsubayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis]Hiroyuki Horiuchi, Uhi Toh, Shinji Uchida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Combination immunotherapy using autologous tumor-stimulated lymphocytes and trastuzumab (Herceptin) for the patients with recurrent breast cancer]Uhi Toh, Teruhiko Fujii, Keisuke Miwa, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Surgery Today|November 13, 2020
Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant techniqueUhi Toh, Miki Takenaka, Nobutaka Iwakuma, et al.
Molecular and Clinical Oncology|May 27, 2022
Immune responses of patients without cancer recurrence after a cancer vaccine over a long termShigetaka Suekane, Shigeru Yutani, Uhi Toh, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusionUhi Toh, Teruhiko Fujii, Naoko Seki, et al.
Breast Cancer (Tokyo, Japan)|August 22, 2014
Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancerMai Mishima, Uhi Toh, Nobutaka Iwakuma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cells（CTC）in Patients with Metastatic Breast Cancer]Mina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
Experimental and Therapeutic Medicine|July 12, 2021
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccinesShuko Saku, Uhi Toh, Yuko Takao, et al.
Current Medicinal Chemistry|March 14, 2008
Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1Teruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Future Oncology (London, England)|March 17, 2009
YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cellsTeruhiko Fujii, Naoko Seki, Roka Namoto-Matsubayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis]Hiroyuki Horiuchi, Uhi Toh, Shinji Uchida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Combination immunotherapy using autologous tumor-stimulated lymphocytes and trastuzumab (Herceptin) for the patients with recurrent breast cancer]Uhi Toh, Teruhiko Fujii, Keisuke Miwa, et al.
Pageof 7